Questions discussed in this category
From a geriatrics harm-reduction standpoint, can we recommend any particulars regarding dosing or selection of therapies when used as a last resort?
Would you consider benzodiazepines for agitation in progressive supranuclear palsy? What other treatment strategies would you consider?
2531925321252432440914876
Papers discussed in this category
Front Neurol, 2021 Jul 01
Semin Neurol, 2022 Apr
Journal of the American Geriatrics Society, 2016 Mar 23
The Cochrane database of systematic reviews, 2018 Jun 18